|
1
|
Singh UP, Singh NP, Singh B, Hofseth LJ,
Price RL, Nagarkatti M and Nagarkatti PS: Resveratrol
(trans-3,5,4′-trihydroxystilbene) induces silent mating type
information regulation-1 and down-regulates nuclear transcription
factor-kappaB activation to abrogate dextran sulfate sodium-induced
colitis. J Pharmacol Exp Ther. 332:829–839. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kimura Y and Okuda H: Resveratrol isolated
from Polygonum cuspidatum root prevents tumor growth and metastasis
to lung and tumor-induced neovascularization in Lewis lung
carcinoma-bearing mice. J Nutr. 131:1844–1849. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schmidlin L, Poutaraud A, Claudel P,
Mestre P, Prado E, Santos-Rosa M, Wiedemann-Merdinoglu S, Karst F,
Merdinoglu D and Hugueney P: A stress-inducible resveratrol
O-methyltransferase involved in the biosynthesis of pterostilbene
in grapevine. Plant Physiol. 148:1630–1639. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Das DK and Maulik N: Resveratrol in
cardioprotection: A therapeutic promise of alternative medicine.
Mol Interv. 6:36–47. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Colin D, Gimazane A, Lizard G, Izard JC,
Solary E, Latruffe N and Delmas D: Effects of resveratrol analogs
on cell cycle progression, cell cycle associated proteins and
5fluoro-uracil sensitivity in human derived colon cancer cells. Int
J Cancer. 124:2780–2788. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bai Q, Shen Y, Yao X, Wang F, Du Y, Wang
Q, Jin N, Hai J, Hu T and Yang J: Modeling a new water channel that
allows SET9 to dimethylate p53. PLoS One. 6:e198562011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ji Q, Liu X, Fu X, Zhang L, Sui H, Zhou L,
Sun J, Cai J, Qin J, Ren J and Li Q: Resveratrol inhibits invasion
and metastasis of colorectal cancer cells via MALAT1 mediated
Wnt/β-catenin signal pathway. PLoS One. 8:e787002013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aoki K and Taketo MM: Adenomatous
polyposis coli (APC): A multi-functional tumor suppressor gene. J
Cell Sci. 120:3327–3335. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Losi L, Luppi G and Benhattar J:
Assessment of K-ras, Smad4 and p53 gene alterations in colorectal
metastases and their role in the metastatic process. Oncol Rep.
12:1221–1225. 2004.PubMed/NCBI
|
|
11
|
Zilfou JT and Lowe SW: Tumor suppressive
functions of p53. Cold Spring Harb Perspect Biol. 1:a0018832009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rada M, Althubiti M, Ekpenyong-Akiba AE,
Lee KG, Lam KP, Fedorova O, Barlev NA and Macip S: BTK blocks the
inhibitory effects of MDM2 on p53 activity. Oncotarget.
8:106639–106647. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rada M, Vasileva E, Lezina L, Marouco D,
Antonov AV, Macip S, Melino G and Barlev N: Human EHMT2/G9a
activates p53 through methylation-independent mechanism. Oncogene.
36:922–932. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bieging KT, Mello SS and Attardi LD:
Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev
Cancer. 14:359–370. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee DH, Kim C, Zhang L and Lee YJ: Role of
p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer
cells. Biochem Pharmacol. 75:2020–2033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marouco D, Garabadgiu AV, Melino G and
Barlev NA: Lysine-specific modifications of p53: A matter of life
and death? Oncotarget. 4:1556–1571. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cong P, Yi C and Wang XY: Expression of
Smo in pancreatic cancer CD44+CD24+ cells and
construction of a lentiviral expression vector to silence Smo.
Oncology Lett. 16:4855–4862. 2018.
|
|
18
|
Hsieh TC, Wang Z, Hamby CV and Wu JM:
Inhibition of melanoma cell proliferation by resveratrol is
correlated with upregulation of quinone reductase 2 and p53.
Biochem Biophys Res Commun. 334:223–230. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Oi N, Yuan J, Malakhova M, Luo K, Li Y,
Ryu J, Zhang L, Bode AM, Xu Z, Li Y, et al: Resveratrol induces
apoptosis by directly targeting Ras-GTPase-activating protein SH3
domain-binding protein 1. Oncogene. 34:2660–2671. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li B, Hou D, Guo H, Zhou H, Zhang S, Xu X,
Liu Q, Zhang X, Zou Y, Gong Y and Shao C: Resveratrol sequentially
induces replication and oxidative stresses to drive p53-CXCR2
mediated cellular senescence in cancer cells. Sci Rep. 7:2082017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shih A, Davis FB, Lin HY and Davis PJ:
Resveratrol induces apoptosis in thyroid cancer cell lines via a
MAPK- and p53-dependent mechanism. J Clin Endocrinol Metab.
87:1223–1232. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mizuno H, Kitada K, Nakai K and Sarai A:
PrognoScan: A new database for meta-analysis of the prognostic
value of genes. BMC Med Genomics. 2(18)2009.PubMed/NCBI
|
|
23
|
Smith JJ, Deane NG, Wu F, Merchant NB,
Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, et al:
Experimentally derived metastasis gene expression profile predicts
recurrence and death in patients with colon cancer.
Gastroenterology. 138:958–968. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Akiyama Y, Koda Y, Byeon SJ, Shimada S,
Nishikawaji T, Sakamoto A, Chen Y, Kojima K, Kawano T, Eishi Y, et
al: Reduced expression of SET7/9, a histone mono-methyltransferase,
is associated with gastric cancer progression. Oncotarget.
7:3966–3983. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Montenegro MF, Sánchez-Del-Campo L,
González-Guerrero R, Martínez-Barba E, Piñero-Madrona A,
Cabezas-Herrera J and Rodríguez-López JN: Tumor suppressor SET9
guides the epigenetic plasticity of breast cancer cells and serves
as an early-stage biomarker for predicting metastasis. Oncogene.
35:6143–6152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Los M, Mozoluk M, Ferrari D, Stepczynska
A, Stroh C, Renz A, Herceg Z, Wang ZQ and Schulze-Osthoff K:
Activation and caspase-mediated inhibition of PARP: A molecular
switch between fibroblast necrosis and apoptosis in death receptor
signaling. Mol Biol Cell. 13:978–988. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Althubiti M, Rada M, Samuel J, Escorsa JM,
Najeeb H, Lee KG, Lam KP, Jones GD, Barlev NA and Macip S: BTK
modulates p53 activity to enhance apoptotic and senescent
responses. Cancer Res. 76:5405–5414. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
West LE and Gozani O: Regulation of p53
function by lysine methylation. Epigenomics. 3:361–369. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chuikov S, Kurash JK, Wilson JR, Xiao B,
Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, et
al: Regulation of p53 activity through lysine methylation. Nature.
432:353–360. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kurash JK, Lei H, Shen Q, Marston WL,
Granda BW, Fan H, Wall D, Li E and Gaudet F: Methylation of p53 by
Set7/9 mediates p53 acetylation and activity in vivo. Mol Cell.
29:392–400. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nishioka K, Chuikov S, Sarma K,
Erdjument-Bromage H, Allis CD, Tempst P and Reinberg D: Set9, a
novel histone H3 methyltransferase that facilitates transcription
by precluding histone tail modifications required for
heterochromatin formation. Genes Dev. 16:479–489. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kai L, Samuel SK and Levenson AS:
Resveratrol enhances p53 acetylation and apoptosis in prostate
cancer by inhibiting MTA1/NuRD complex. Int J Cancer.
126:1538–1548. 2010.PubMed/NCBI
|
